AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Genes & Diseases Article
PDF (1 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Construction and validation of a novel SUMOylation-related lncRNAs signature for predicting the prognosis, tumor immune microenvironment, and therapeutic sensitivity of lung adenocarcinoma

Jie Caia,1, Weizhong Ruanb,1, Zida Wangc,1, Gongzhe Liud, Bei Yanga, Hao Wanga, Deping Zhaoa( ), Chang Chena( ), Xiaogang Zhaoa( )
Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China
Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, Fujian 350014, China
Department of Emergency, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China
Department of Cardiothoracic Surgery, People’s Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 271199, China

1 These authors have contributed equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

References

1

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.
Crossref Google Scholar
2

Chaft JE, Rimner A, Weder W, Azzoli CG, Kris MG, Cascone T. Evolution of systemic therapy for stages Ⅰ-Ⅲ non-metastatic non-small-cell lung cancer. Nat Rev Clin Oncol. 2021;18(9):547-557.
Crossref Google Scholar
3

Xie M, Yu J, Ge S, Huang J, Fan X. SUMOylation homeostasis in tumorigenesis. Cancer Lett. 2020;469:301-309.
Google Scholar
4

Hu FF, Liu CJ, Liu LL, Zhang Q, Guo AY. Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response. Briefings Bioinf. 2021;22(3):bbaa176.
Google Scholar
5

Chan TA, Yarchoan M, Jaffee E, et al. Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Ann Oncol. 2019;30(1):44-56.
Crossref Google Scholar
Genes & Diseases
Volume 12 Issue 2,
March 2025
Article number: 101338
DOI: 10.1016/j.gendis.2024.101338
Cite this article:
Cai J, Ruan W, Wang Z, et al. Construction and validation of a novel SUMOylation-related lncRNAs signature for predicting the prognosis, tumor immune microenvironment, and therapeutic sensitivity of lung adenocarcinoma. Genes & Diseases, 2025, 12(2): 101338. https://doi.org/10.1016/j.gendis.2024.101338

60

Views

2

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Altmetrics
Received: 21 October 2023
Published: 28 May 2024
© 2024 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Return